On-the-spot Detection of COVID-19: A New Diagnostic Tool
Researchers at the University of Warwick have developed a new diagnostic tool to detect COVID-19 on the spot. This could change the way we do mass testing for COVID-19. Currently, there is an urgent need for new diagnostics, especially those which give rapid results for screening of healthcare professionals and high-risk individuals. This new diagnostic tool uses glycans (sialic acids) in the lateral flow device. An important benefit of using glycans is that it detects only intact viruses and thus can easily detect active infections. The researchers have tested this tool on a pseudotyped virus with great results and further research is underway to optimise the detection limits. The diagnostic tool contains paper-based polymer-stabilized, multivalent gold nanoparticles bearing sialic acid derivatives in lateral flow device. The advantages of using such devices are that it requires no centralized infrastructure and little or no clinical training. Additionally, the technology is extremely low-cost as the kit is paper-based.
Nice
Informative and educative post. Early detection and early treatment is a key with prevention of this red dragon.
Excellent and very much informative article. Thanks for your valuable news Sir.
Informative Yes early detection is need of hour in giving treatment
Cases that would interest you
- Login to View the image
A 60-year-old male presented with cough and dyspnea. He is a known Sarcoidosis patient. He is on cortisol treatment for 6 months. New Chest CT shows multiple mediastinal lymph nodes, interstitial sarcoidosis findings, and Pleural thickening. Newly presented Chest CT is almost same. Additionally bilateral ground-glass densities. The question: Is it alveolar Sarcoidosis or COVID 19?
Dr. Ishan Ghorila10 Likes18 Answers - Login to View the image
44-year-old male, stigmata of HIV, presented with shortness and respiratory distress. Patient was intimated and sedated. The patient is a known MDR-TB patient, on further investigation found to have completed treatment in 2015. Other history was not obtained. On arrival patient x/ray reviewed (attached - Image 1) and bilateral infiltrates noted as well as ? right lung mass. The patient sent for urgent non-contrast CTB (NAD) and chest. CT findings: ‘Basal infiltrates bilaterally, no cavities, faint effusions with no gross adenopathy. Active TB is very unlikely. Cardiomegaly with PAH. Paraseptal emphysema - mild degree only. Right pericardiac mass (mediastinal).” Patient management is ongoing. What are your valuable suggestions?
Dr. Akhil Sharma8 Likes36 Answers - Login to View the image
Patient in early 50s who has a history of SARS when it was going round. Presents with shortness of breath, oxygen saturation in high 80s despite no chronic pulmonary disease. The patient seems to be coping well, but when do you decide to proceed to intubation assuming this is COVID-19? Watch and observe until they begin to deteriorate, or intubate while still well?
Dr. Zaka Yusto M2 Likes23 Answers - Login to View the image
Geriatric female with PMHx DM, HTN, A fib on Xarelto, chronic facial asymmetry present to ED following fall at home, change in mental status and febrile. Suggestions? Should I sent for COVID-19 test.
Dr. Harshita Jain3 Likes26 Answers - Login to View the image
A 45-year-old female presented with the following symptoms - Shortness of breath - Productive cough last 2 weeks - Weight loss - Fever Background history - HIV positive on 2nd line ARVs - Unknown CD4 and viral count - No known covid contacts On examination - Vitals: BP 143/92, HR 123, Sats: 52% on RA and 94% on polymask O2, RR- 38 - General: increased BMI, half-and-half nails, generalized lymphadenopathy - Resp: mild alar flaring, SCR, scattered crackles. - others systems: nothing of note What special investigations would you like to do and what would be your differential diagnoses?
Dr. Harshita Jain2 Likes29 Answers
3 Likes